Urigen Pharmaceuticals Inc - Strategic SWOT Analysis Review

  • ID: 4429756
  • SWOT Analysis
  • 21 pages
  • GlobalData
1 of 5

FEATURED COMPANIES

  • Halozyme Therapeutics Inc
  • Mission Pharmacal Company
  • rEVO Biologics Inc
  • Riot Blockchain Inc
  • Telesta Therapeutics Inc
  • MORE
Urigen Pharmaceuticals Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services.

This up-to-the-minute company report will help you to formulate strategies to drive your business by enabling you to understand your partners, customers and competitors better.

Scope
  • Business description - A detailed description of the company’s operations and business divisions.
  • Corporate strategy - Summarization of the company’s business strategy.
  • SWOT analysis - A detailed analysis of the company’s strengths, weakness, opportunities and threats.
  • Company history - Progression of key events associated with the company.
  • Major products and services - A list of major products, services and brands of the company.
  • Key competitors - A list of key competitors to the company.
  • Key employees - A list of the key executives of the company.
  • Executive biographies - A brief summary of the executives’ employment history.
  • Key operational heads - A list of personnel heading key departments/functions.
  • Important locations and subsidiaries - A list of key locations and subsidiaries of the company, including contact details.
  • Key manufacturing facilities - A list of key manufacturing facilities of the company.
Highlights

Urigen Pharmaceuticals Inc (Urigen) is a specialty pharmaceutical company that develops and commercializes therapeutic products for urological disorders. The company focuses on developing innovative products for amelioration of urethritis, painful bladder syndrome (PBS), nocturia and over active bladder (OAB). Its pipeline includes its flagship candidate, URG101, being developed for the painful bladder syndrome/interstitial cystitis. The company licensed URG101, is a proprietary combination therapy for the relief of pain of bladder. Its other product candidate, URG501, is in pre-clinical development. Urigen is headquartered in North Brunswick, New Jersey, the US.

Reasons to Buy
  • Gain key insights into the company for academic or business research purposes. Key elements such as SWOT analysis and corporate strategy are incorporated in the profile to assist your academic or business research needs.
  • Identify potential customers and suppliers with this report’s analysis of the company’s business structure, operations, major products and services and business strategy.
  • Understand and respond to your competitors’ business structure and strategies with this detailed SWOT analysis. In this, the company’s core strengths, weaknesses, opportunities and threats are analyzed, providing you with an up to date objective view of the company.
  • Examine potential investment and acquisition targets with this report’s detailed insight into the company’s strategic, business and operational performance.
Note: Some sections may be missing if data is unavailable for the company.
READ MORE
Note: Product cover images may vary from those shown
2 of 5

FEATURED COMPANIES

  • Halozyme Therapeutics Inc
  • Mission Pharmacal Company
  • rEVO Biologics Inc
  • Riot Blockchain Inc
  • Telesta Therapeutics Inc
  • MORE
Section 1 - About the Company
  • Urigen Pharmaceuticals Inc - Key Facts
  • Urigen Pharmaceuticals Inc - Key Employees
  • Urigen Pharmaceuticals Inc - Key Employee Biographies
  • Urigen Pharmaceuticals Inc - Major Products and Services
  • Urigen Pharmaceuticals Inc - History
  • Urigen Pharmaceuticals Inc - Locations And Subsidiaries
  • Head Office
Section 2 - Company Analysis
  • Urigen Pharmaceuticals Inc - Business Description
  • Urigen Pharmaceuticals Inc - SWOT Analysis
  • SWOT Analysis - Overview
  • Urigen Pharmaceuticals Inc - Strengths
  • Urigen Pharmaceuticals Inc - Weaknesses
  • Urigen Pharmaceuticals Inc - Opportunities
  • Urigen Pharmaceuticals Inc - Threats
  • Urigen Pharmaceuticals Inc - Key Competitors
Section 3 - Company’s Lifesciences Financial Deals and Alliances
  • Urigen Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017
  • Urigen Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Type, 2011 to YTD 2017
  • Urigen Pharmaceuticals Inc, Recent Deals Summary
Section 4 - Appendix
  • Methodology
List of Tables
  • Urigen Pharmaceuticals Inc, Key Facts
  • Urigen Pharmaceuticals Inc, Key Employees
  • Urigen Pharmaceuticals Inc, Key Employee Biographies
  • Urigen Pharmaceuticals Inc, Major Products and Services
  • Urigen Pharmaceuticals Inc, History
  • Urigen Pharmaceuticals Inc, Key Competitors
  • Urigen Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017
  • Urigen Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Type, 2011 to YTD 2017
  • Urigen Pharmaceuticals Inc, Recent Deals Summary
List of Figures
  • Urigen Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017
  • Urigen Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals by Type, 2011 to YTD 2017
Note: Product cover images may vary from those shown
3 of 5

Loading
LOADING...

4 of 5
  • Halozyme Therapeutics Inc
  • Janssen Pharmaceuticals Inc
  • Mission Pharmacal Company
  • Plethora Solutions Holdings Plc
  • rEVO Biologics Inc
  • Riot Blockchain Inc
  • Telesta Therapeutics Inc
Note: Product cover images may vary from those shown
5 of 5
Note: Product cover images may vary from those shown
Adroll
adroll